Literature DB >> 24048571

Mechanisms of adverse cardiometabolic consequences of obesity.

Carlos M Diaz-Melean1, Virend K Somers, Juan Pablo Rodriguez-Escudero, Prachi Singh, Ondrej Sochor, Ernesto Manuel Llano, Francisco Lopez-Jimenez.   

Abstract

Obesity is an epidemic that threatens the health of millions of people worldwide and is a major risk factor for cardiovascular diseases, hypertension, diabetes, and dyslipidemia. There are multiple and complex mechanisms to explain how obesity can cause cardiovascular disease. In recent years, studies have shown some limitations in the way we currently define obesity and assess adiposity. This review focuses on the mechanisms involved in the cardiometabolic consequences of obesity and on the relationship between obesity and cardiovascular comorbidities, and provides a brief review of the latest studies focused on normal weight obesity and the obesity paradox.

Entities:  

Mesh:

Year:  2013        PMID: 24048571     DOI: 10.1007/s11883-013-0364-2

Source DB:  PubMed          Journal:  Curr Atheroscler Rep        ISSN: 1523-3804            Impact factor:   5.113


  98 in total

1.  Leptin-induced vascular smooth muscle cell proliferation via regulating cell cycle, activating ERK1/2 and NF-kappaB.

Authors:  Fen Huang; Xiaofang Xiong; Huabin Wang; Sha You; Hesong Zeng
Journal:  Acta Biochim Biophys Sin (Shanghai)       Date:  2010-05-15       Impact factor: 3.848

Review 2.  Obstructive sleep apnoea.

Authors:  Atul Malhotra; David P White
Journal:  Lancet       Date:  2002-07-20       Impact factor: 79.321

Review 3.  Perivascular adipose tissue as a cause of atherosclerosis.

Authors:  Sandra N Verhagen; Frank L J Visseren
Journal:  Atherosclerosis       Date:  2010-06-01       Impact factor: 5.162

4.  Leptin induces mitochondrial superoxide production and monocyte chemoattractant protein-1 expression in aortic endothelial cells by increasing fatty acid oxidation via protein kinase A.

Authors:  S I Yamagishi ; D Edelstein; X L Du; Y Kaneda; M Guzmán; M Brownlee
Journal:  J Biol Chem       Date:  2001-05-07       Impact factor: 5.157

5.  Normal weight obesity: a risk factor for cardiometabolic dysregulation and cardiovascular mortality.

Authors:  Abel Romero-Corral; Virend K Somers; Justo Sierra-Johnson; Yoel Korenfeld; Simona Boarin; Josef Korinek; Michael D Jensen; Gianfranco Parati; Francisco Lopez-Jimenez
Journal:  Eur Heart J       Date:  2009-11-20       Impact factor: 29.983

6.  Atrial fibrillation and obesity--results of a meta-analysis.

Authors:  Nikolas Wanahita; Franz H Messerli; Sripal Bangalore; Apoor S Gami; Virend K Somers; Jonathan S Steinberg
Journal:  Am Heart J       Date:  2007-12-19       Impact factor: 4.749

7.  Early ghrelin treatment after myocardial infarction prevents an increase in cardiac sympathetic tone and reduces mortality.

Authors:  Daryl O Schwenke; Takeshi Tokudome; Ichiro Kishimoto; Takeshi Horio; Mikiyasu Shirai; Patricia A Cragg; Kenji Kangawa
Journal:  Endocrinology       Date:  2008-07-03       Impact factor: 4.736

Review 8.  Molecular mechanisms of cardiovascular disease in OSAHS: the oxidative stress link.

Authors:  L Lavie; P Lavie
Journal:  Eur Respir J       Date:  2009-06       Impact factor: 16.671

9.  Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study.

Authors:  H B Hubert; M Feinleib; P M McNamara; W P Castelli
Journal:  Circulation       Date:  1983-05       Impact factor: 29.690

10.  Leptin stimulates rat aortic smooth muscle cell proliferation and migration.

Authors:  A Oda; T Taniguchi; M Yokoyama
Journal:  Kobe J Med Sci       Date:  2001-06
View more
  9 in total

Review 1.  Normal-weight obesity: implications for cardiovascular health.

Authors:  Nathalie Jean; Virend K Somers; Ondrej Sochor; Jose Medina-Inojosa; Ernesto M Llano; Francisco Lopez-Jimenez
Journal:  Curr Atheroscler Rep       Date:  2014-12       Impact factor: 5.113

2.  Temporal patterns of self-weighing behavior and weight changes assessed by consumer purchased scales in the Health eHeart Study.

Authors:  Yaguang Zheng; Susan M Sereika; Lora E Burke; Jeffrey E Olgin; Gregory M Marcus; Kirstin Aschbacher; Geoffrey H Tison; Mark J Pletcher
Journal:  J Behav Med       Date:  2019-01-16

Review 3.  Diabetes, sleep apnea, obesity and cardiovascular disease: Why not address them together?

Authors:  Salim R Surani
Journal:  World J Diabetes       Date:  2014-06-15

Review 4.  Cardiovascular and Metabolic Heterogeneity of Obesity: Clinical Challenges and Implications for Management.

Authors:  Ian J Neeland; Paul Poirier; Jean-Pierre Després
Journal:  Circulation       Date:  2018-03-27       Impact factor: 29.690

Review 5.  New insight into adiponectin role in obesity and obesity-related diseases.

Authors:  Ersilia Nigro; Olga Scudiero; Maria Ludovica Monaco; Alessia Palmieri; Gennaro Mazzarella; Ciro Costagliola; Andrea Bianco; Aurora Daniele
Journal:  Biomed Res Int       Date:  2014-07-07       Impact factor: 3.411

6.  Effects of C-reactive protein on the expression of matrix metalloproteinases and their inhibitors via Fcγ receptors on 3T3-L1 adipocytes.

Authors:  Kumiko Nakai; Hideki Tanaka; Kazuhiro Yamanaka; Yumi Takahashi; Fumiko Murakami; Rieko Matsuike; Jumpei Sekino; Natsuko Tanabe; Toyoko Morita; Yoji Yamazaki; Takayuki Kawato; Masao Maeno
Journal:  Int J Med Sci       Date:  2017-04-09       Impact factor: 3.738

7.  Genistein Supplementation and Cardiac Function in Postmenopausal Women with Metabolic Syndrome: Results from a Pilot Strain-Echo Study.

Authors:  Cesare De Gregorio; Herbert Marini; Angela Alibrandi; Antonino Di Benedetto; Alessandra Bitto; Elena Bianca Adamo; Domenica Altavilla; Concetta Irace; Giacoma Di Vieste; Diego Pancaldo; Roberta Granese; Marco Atteritano; Salvatore Corrao; Giuseppe Licata; Francesco Squadrito; Vincenzo Arcoraci
Journal:  Nutrients       Date:  2017-06-07       Impact factor: 5.717

8.  An in vitro study of lipase inhibitory peptides obtained from de-oiled rice bran.

Authors:  Titima Ketprayoon; Sajee Noitang; Papassara Sangtanoo; Piroonporn Srimongkol; Tanatorn Saisavoey; Onrapak Reamtong; Kiattawee Choowongkomon; Aphichart Karnchanatat
Journal:  RSC Adv       Date:  2021-05-25       Impact factor: 4.036

9.  Metabolic syndrome is associated with a poor outcome in patients affected by outflow tract premature ventricular contractions treated by catheter ablation.

Authors:  Celestino Sardu; Giovanni Carreras; Spyridon Katsanos; Vasileios Kamperidis; Maria Caterina Pace; Maria Beatrice Passavanti; Ilaria Fava; Pasquale Paolisso; Gorizio Pieretti; Giovanni Francesco Nicoletti; Gaetano Santulli; Giuseppe Paolisso; Raffaele Marfella
Journal:  BMC Cardiovasc Disord       Date:  2014-12-06       Impact factor: 2.298

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.